Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Haploidentical Allogeneic Peripheral Blood Transplantation: Clinical Trial and Laboratory Correlates Examining Checkpoint Immune Regulators' Expression

NCT03480360 is registered in ClinicalTrials.gov with Dartmouth-Hitchcock Medical Center as lead sponsor.

NCT NCT03480360
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03480360 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Haploidentical Allogeneic Peripheral Blood Transplantation: Clinical Trial and Laboratory Correlates Examining Checkpoint Immune Regulators' Expression
Lead sponsor
Dartmouth-Hitchcock Medical Center
Phase
Phase 3
Overall status
Completed
Start date
March 28, 2018
Completion date
October 17, 2025
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia, chronic lymphocytic leukemia, chronic myeloid leukemia, lymphoma, lymphoma, non-hodgkin, myelodysplasia, myelofibrosis, myeloproliferative disorder, plasma cell disorder